Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
Go back to Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 5.91 -0.03 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.94 | 52 Week High | $44.38 | |||
| Open | $5.96 | 52 Week Low | $24.47 | |||
| Day High | $6.11 | P/E | 295.50 | |||
| Day Low | $5.88 | EPS | $0.02 | |||
| Volume | 1,244,031 | |||||
